Additionally, Biocon has obtained an Establishment Inspection Report (EIR) from the US FDA for its greenfield API facility in Visakhapatnam, clearing the way for commercial supplies to the US market.

India's Biocon has partnered with US-based Mylan to sell Indian-made biogenerics globally. Bangalore-based Biocon sees the collaboration with Mylan, the world's third-largest generics producer ...